Genetic analysis reveals functions of atypical polyubiquitin chains

  1. Fernando Meza Gutierrez
  2. Deniz Simsek
  3. Arda Mizrak
  4. Adam Deutschbauer
  5. Hannes Braberg
  6. Jeffrey Johnson
  7. Jiewei Xu
  8. Michael Shales
  9. Michelle Nguyen
  10. Raquel Tamse-Kuehn
  11. Curt Palm
  12. Lars M Steinmetz
  13. Nevan J Krogan
  14. David P Toczyski  Is a corresponding author
  1. University of California, San Francisco, United States
  2. Amgen Research, United States
  3. Lawrence Berkeley National Laboratory, United States
  4. Stanford University, United States
  5. University of California San Francisco, United States

Abstract

Although polyubiquitin chains linked through all lysines of ubiquitin exist, specific functions are well-established only for lysine-48 and lysine-63 linkages in Saccharomyces cerevisiae. To uncover pathways regulated by distinct linkages, genetic interactions between a gene deletion library and a panel of lysine-to-arginine ubiquitin mutants were systematically identified. The K11R mutant had strong genetic interactions with threonine biosynthetic genes. Consistently, we found that K11R mutants import threonine poorly. The K11R mutant also exhibited a strong genetic interaction with a subunit of the anaphase-promoting complex (APC), suggesting a role in cell cycle regulation. K11-linkages are important for vertebrate APC function, but this was not previously described in yeast. We show that the yeast APC also modifies substrates with K11-linkages in vitro, and that those chains contribute to normal APC-substrate turnover in vivo. This study reveals comprehensive genetic interactomes of polyubiquitin chains and characterizes the role of K11-chains in two biological pathways.

Data availability

All datasets generated are included as Supplementary Files 4 (SGA dataset) and 5 (quantitative proteomics).

Article and author information

Author details

  1. Fernando Meza Gutierrez

    Department of Biochemistry and Biophysics, University of California, San Francisco, San Francisco, United States
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-5601-7202
  2. Deniz Simsek

    Amgen Research, South San Francisco, United States
    Competing interests
    Deniz Simsek, is affiliated with Amgen Research. The author has no other competing interests to declare..
  3. Arda Mizrak

    Department of Biochemistry and Biophysics, University of California, San Francisco, San Francisco, United States
    Competing interests
    No competing interests declared.
  4. Adam Deutschbauer

    Lawrence Berkeley National Laboratory, Berkeley, United States
    Competing interests
    No competing interests declared.
  5. Hannes Braberg

    Department of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, United States
    Competing interests
    No competing interests declared.
  6. Jeffrey Johnson

    Department of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, United States
    Competing interests
    No competing interests declared.
  7. Jiewei Xu

    Department of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, United States
    Competing interests
    No competing interests declared.
  8. Michael Shales

    Department of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, United States
    Competing interests
    No competing interests declared.
  9. Michelle Nguyen

    Stanford Genome Technology Center, Stanford University, Stanford, United States
    Competing interests
    No competing interests declared.
  10. Raquel Tamse-Kuehn

    Stanford Genome Technology Center, Stanford University, Stanford, United States
    Competing interests
    No competing interests declared.
  11. Curt Palm

    Stanford Genome Technology Center, Stanford University, Stanford, United States
    Competing interests
    No competing interests declared.
  12. Lars M Steinmetz

    Genetics, Stanford University, Stanford, United States
    Competing interests
    No competing interests declared.
  13. Nevan J Krogan

    Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, United States
    Competing interests
    No competing interests declared.
  14. David P Toczyski

    Department of Biochemistry and Biophysics, University of California, San Francisco, San Francisco, United States
    For correspondence
    dpt4darwin@gmail.com
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-5924-0365

Funding

National Institutes of Health (R35 GM118104)

  • David P Toczyski

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Reviewing Editor

  1. Michael Rape, University of California, Berkeley, United States

Version history

  1. Received: October 18, 2018
  2. Accepted: November 30, 2018
  3. Accepted Manuscript published: December 14, 2018 (version 1)
  4. Version of Record published: December 24, 2018 (version 2)

Copyright

© 2018, Meza Gutierrez et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 1,981
    views
  • 268
    downloads
  • 11
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Fernando Meza Gutierrez
  2. Deniz Simsek
  3. Arda Mizrak
  4. Adam Deutschbauer
  5. Hannes Braberg
  6. Jeffrey Johnson
  7. Jiewei Xu
  8. Michael Shales
  9. Michelle Nguyen
  10. Raquel Tamse-Kuehn
  11. Curt Palm
  12. Lars M Steinmetz
  13. Nevan J Krogan
  14. David P Toczyski
(2018)
Genetic analysis reveals functions of atypical polyubiquitin chains
eLife 7:e42955.
https://doi.org/10.7554/eLife.42955

Share this article

https://doi.org/10.7554/eLife.42955

Further reading

    1. Biochemistry and Chemical Biology
    2. Plant Biology
    Henning Mühlenbeck, Yuko Tsutsui ... Cyril Zipfel
    Research Article

    Transmembrane signaling by plant receptor kinases (RKs) has long been thought to involve reciprocal trans-phosphorylation of their intracellular kinase domains. The fact that many of these are pseudokinase domains, however, suggests that additional mechanisms must govern RK signaling activation. Non-catalytic signaling mechanisms of protein kinase domains have been described in metazoans, but information is scarce for plants. Recently, a non-catalytic function was reported for the leucine-rich repeat (LRR)-RK subfamily XIIa member EFR (elongation factor Tu receptor) and phosphorylation-dependent conformational changes were proposed to regulate signaling of RKs with non-RD kinase domains. Here, using EFR as a model, we describe a non-catalytic activation mechanism for LRR-RKs with non-RD kinase domains. EFR is an active kinase, but a kinase-dead variant retains the ability to enhance catalytic activity of its co-receptor kinase BAK1/SERK3 (brassinosteroid insensitive 1-associated kinase 1/somatic embryogenesis receptor kinase 3). Applying hydrogen-deuterium exchange mass spectrometry (HDX-MS) analysis and designing homology-based intragenic suppressor mutations, we provide evidence that the EFR kinase domain must adopt its active conformation in order to activate BAK1 allosterically, likely by supporting αC-helix positioning in BAK1. Our results suggest a conformational toggle model for signaling, in which BAK1 first phosphorylates EFR in the activation loop to stabilize its active conformation, allowing EFR in turn to allosterically activate BAK1.

    1. Biochemistry and Chemical Biology
    2. Cell Biology
    Ya-Juan Wang, Xiao-Jing Di ... Ting-Wei Mu
    Research Article Updated

    Protein homeostasis (proteostasis) deficiency is an important contributing factor to neurological and metabolic diseases. However, how the proteostasis network orchestrates the folding and assembly of multi-subunit membrane proteins is poorly understood. Previous proteomics studies identified Hsp47 (Gene: SERPINH1), a heat shock protein in the endoplasmic reticulum lumen, as the most enriched interacting chaperone for gamma-aminobutyric acid type A (GABAA) receptors. Here, we show that Hsp47 enhances the functional surface expression of GABAA receptors in rat neurons and human HEK293T cells. Furthermore, molecular mechanism study demonstrates that Hsp47 acts after BiP (Gene: HSPA5) and preferentially binds the folded conformation of GABAA receptors without inducing the unfolded protein response in HEK293T cells. Therefore, Hsp47 promotes the subunit-subunit interaction, the receptor assembly process, and the anterograde trafficking of GABAA receptors. Overexpressing Hsp47 is sufficient to correct the surface expression and function of epilepsy-associated GABAA receptor variants in HEK293T cells. Hsp47 also promotes the surface trafficking of other Cys-loop receptors, including nicotinic acetylcholine receptors and serotonin type 3 receptors in HEK293T cells. Therefore, in addition to its known function as a collagen chaperone, this work establishes that Hsp47 plays a critical and general role in the maturation of multi-subunit Cys-loop neuroreceptors.